SCHEMBL24817702

SCHEMBL24817702

COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3P(C)(C)=O)n1)CCN(C1CCNCC1)C2

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 12/20 0.81
▸ ALK Q9UM73 8/20 0.74
▸ INSR P06213 4/20 0.64
▸ IGF1R P08069 4/20 0.64
▸ CHEK1 O14757 1/20 0.63
▸ AURKA O14965 1/20 0.63
▸ NUAK1 O60285 1/20 0.63
▸ JAK2 O60674 1/20 0.63
▸ STK10 O94804 1/20 0.63
▸ PRKD3 O94806 1/20 0.63
▸ SLC34A2 O95436 1/20 0.63
▸ CHEK2 O96017 1/20 0.63
▸ ABL1 P00519 1/20 0.63
▸ EGFR P00533 1/20 0.63
▸ CD74 P04233 1/20 0.63
▸ ERBB2 P04626 1/20 0.63
▸ LCK P06239 1/20 0.63
▸ FYN P06241 1/20 0.63
▸ FES P07332 1/20 0.63
▸ CSF1R P07333 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20214493 0.90 MAP4K1 (1.00) MAP4K1ALKINSRIGF1R
SCHEMBL24817701 0.88 MAP4K1 (0.73) MAP4K1ALKINSRIGF1RCHEK1
SCHEMBL20214415 0.86 MAP4K1 (1.00) MAP4K1ALKINSRIGF1R
SCHEMBL24040082 0.86 MAP4K1 (1.00) MAP4K1ALKINSRIGF1R
SCHEMBL20214585 0.86 MAP4K1 (1.00) MAP4K1ALKINSRIGF1R
SCHEMBL24039993 0.85 MAP4K1 (0.76) MAP4K1ALKINSRIGF1RCHEK1
SCHEMBL18875078 0.85 ALK (1.00) ALKINSR
SCHEMBL18760004 0.85 ALK (1.00) ALKINSR
SCHEMBL24816848 0.85 ALK (0.76) MAP4K1ALKINSRIGF1RCHEK1
SCHEMBL24040079 0.84 MAP4K1 (0.81) MAP4K1ALK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022268229-A1 PROTEIN INHIBITOR OR DEGRADING AGENT, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND PHARMACEUTICAL USE 和径医药科技(上海)有限公司 2022-12-29 — — WO disclosed
Send feedback